UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 21, 2023
Accession Number:
0001140361-23-018930
Submission Type:
POS AM
CIK:
0001783010
Company Name:
Amryt Pharma plc
File Number:
333-258557